SCHEMBL7968916

SCHEMBL7968916

CCOC(Cc1ccc(OCCC=C2c3occc3-c3ccoc32)cc1)C(=O)O

nearest known ligand 0.65

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARG P37231 14/20 0.65
PPARA Q07869 17/20 0.61
PPARD Q03181 7/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7968986 0.91 PPARG (0.54) PPARGPPARAPPARD
SCHEMBL7966061 0.90 PPARA (0.70) PPARGPPARAPPARD
SCHEMBL7966208 0.90 PPARG (0.53) PPARGPPARAPPARD
SCHEMBL7968512 0.85 PPARG (0.47) PPARGPPARAPPARD
SCHEMBL6739034 0.83 PPARG (0.79) PPARGPPARAPPARD
SCHEMBL6739037 0.83 PPARG (0.79) PPARGPPARAPPARD
SCHEMBL6731789 0.83 PPARG (0.83) PPARGPPARAPPARD
SCHEMBL7965108 0.80 PPARA (0.57) PPARGPPARAPPARD
SCHEMBL7963791 0.80 PPARG (0.68) PPARGPPARAPPARD
SCHEMBL6731219 0.79 PPARA (0.80) PPARGPPARAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6300339-B1 USEFUL FOR THRERAPY AND/OR PROPHYLAXIS OF INSULIN RESISTANCE (TYPE 2 DIABETES), IMPAIRED GLUCOSE TOLERANCE, DYSLIPIDEMIA, HYPERTENSION, OBESITY, INSULIN RESISTANCE, HYPERGLYCEMIA, ATHEROSCLEROSIS, HYPERLIPIDEMIA, CORONARY ARTERY DISEASE NOVO NORDISK A/S (DK) 2001-10-09 US disclosed